These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis. Havel J; Patocka J; Bocaz G J Capill Electrophor Microchip Technol; 2002; 7(5-6):107-12. PubMed ID: 12546159 [TBL] [Abstract][Full Text] [Related]
9. The effect of pH and sodium metabisulphite on the stability of physostigmine sulphate solutions to heat and ionizing radiation. Fletcher G; Davies DJ J Pharm Pharmacol; 1968 Dec; 20():Suppl:108S+. PubMed ID: 4388142 [No Abstract] [Full Text] [Related]
10. Proceedings of the 3rd Symposium on stabilization and evaluation methodology of pharmaceutical preparations, Nagoya Distinction and identification of drug binding sites on human serum albumin by kinetic method appling the esterase-like activity. J Pharmacobiodyn; 1980 Sep; 3(9):s1-11. PubMed ID: 7463304 [No Abstract] [Full Text] [Related]
11. [Determination of geneserine in pharmaceutical solutions]. GLOESENER E J Pharm Belg; 1958; 13(3-4):117-20. PubMed ID: 13550058 [No Abstract] [Full Text] [Related]
12. The absolute configuration of physostigmine. Hill RK; Newkome GR Tetrahedron; 1969 Mar; 25(6):1249-60. PubMed ID: 5346203 [No Abstract] [Full Text] [Related]
13. Differential spectrophotometric estimation of some pharmaceutical compounds. I. Applying relative absorbance value. Abdine H; el-Sayed MA; Ibrahim SA Planta Med; 1973 Jun; 23(4):398-400. PubMed ID: 4732122 [No Abstract] [Full Text] [Related]
14. [Stability testing of drug substances and preparations, a contribution to drug safety]. Kny L; Stark A Pharmazie; 1983 Oct; 38(10):666-70. PubMed ID: 6657735 [No Abstract] [Full Text] [Related]
19. Factorial designs in pharmaceutical preformulation studies. II. Studies on drug stability and compatibility in the solid state. Ahlneck C; Waltersson JO Acta Pharm Suec; 1986; 23(3):139-50. PubMed ID: 3766159 [No Abstract] [Full Text] [Related]
20. Skin permeation of physostigmine from fatty acids-based formulations: evaluating the choice of solvent. Wang MY; Yang YY; Heng PW Int J Pharm; 2005 Feb; 290(1-2):25-36. PubMed ID: 15664127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]